FDA Taking New Steps to Better Inform Physicians about Biosimilars Through Education about these Potentially Cost-Saving Options

By: Scott Gottlieb, M.D., and Leah Christl, Ph.D. The cost of prescription drugs is an ongoing concern, however, a growing market for potentially lower-cost biological products called biosimilars can offer more competition and options for patients. Biosimilars can potentially reduce … Continue reading →
Source: FDA Voice - Category: American Health Source Type: blogs